Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Pharma
Legend Biotech drops 16% as soft 2027 outlook tests new CEO
Despite Carvykti’s growth momentum, Legend warned investors that current sales consensus for 2027 sits “at the higher end” of internal projections.
Angus Liu
Nov 11, 2026 10:19am
Cellares, GenomeFrontier to evaluate CAR-T therapy production
Sep 16, 2026 2:02pm
Legend Biotech names Novartis veteran Ingrid Zhang as new CEO
Sep 16, 2026 10:12am
Legend interim CEO talks transition, Carvykti challenges
Aug 12, 2026 2:44pm
Legend Biotech CEO resigns; search underway for replacement
Jul 27, 2026 9:32am
J&J bispecific combo delivers 89% PFS benefit in myeloma
Jul 23, 2026 8:30am
